KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Other Non Operating Income (2017 - 2025)

LifeMD (LFMD) has disclosed Other Non Operating Income for 5 consecutive years, with -$1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income changed N/A year-over-year to -$1.2 million, compared with a TTM value of -$1.2 million through Sep 2025, changed N/A, and an annual FY2025 reading of $103557.0, up 131.84% over the prior year.
  • Other Non Operating Income was -$1.2 million for Q3 2025 at LifeMD, down from -$325198.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $184914.0 in Q1 2021 and bottomed at -$7.3 million in Q4 2021.
  • Average Other Non Operating Income over 3 years is -$1.9 million, with a median of -$1.1 million recorded in 2021.
  • Peak annual rise in Other Non Operating Income hit 355.0% in 2021, while the deepest fall reached 603.75% in 2021.
  • Year by year, Other Non Operating Income stood at -$7.3 million in 2021, then skyrocketed by 95.56% to -$325198.0 in 2023, then tumbled by 269.01% to -$1.2 million in 2025.
  • Business Quant data shows Other Non Operating Income for LFMD at -$1.2 million in Q3 2025, -$325198.0 in Q1 2023, and -$7.3 million in Q4 2021.